Massachusetts And Nice

MADIT-CRT Trial Data Show Women Received Greater Benefit From CRT-Ds Than Men

Older News

NATICK, Massachusetts and NICE, France, June 18, 2010 - Boston Scientific Corporation (NYSE: BSX) today announced results from a sub-analysis of the MADIT-CRT trial data that showed women received a greater clinical benefit from its cardiac resynchronization therapy defibrillators (CRT-Ds) than men.

MORE..

Corporate
|
Products
|
About Me
|
Contact
|
Privacy Policy